Digestive & Intestinal Remedies (Pharmacies) - Bahrain

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$15.84m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 2.79%, resulting in a market volume of US$18.17m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$10.57 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies (Pharmacies) market in Bahrain has been experiencing significant growth in recent years.

Customer preferences: Customers in Bahrain have shown a growing interest in digestive and intestinal remedies due to various factors. One of the key factors driving this trend is the increasing awareness about the importance of digestive health and the impact it has on overall well-being. As people become more health-conscious, they are seeking out products that can help alleviate digestive issues and promote a healthy gut. Additionally, the convenience of purchasing these remedies from pharmacies has also contributed to their popularity among customers.

Trends in the market: One of the notable trends in the Digestive & Intestinal Remedies market in Bahrain is the rising demand for natural and herbal remedies. Customers are increasingly opting for products that are made from natural ingredients and are free from artificial additives. This trend is driven by a growing preference for holistic and sustainable healthcare solutions. Furthermore, there has been a shift towards preventive healthcare, with customers proactively seeking remedies that can help maintain a healthy digestive system.

Local special circumstances: Bahrain has a high prevalence of digestive disorders, which has further fueled the demand for Digestive & Intestinal Remedies. Factors such as a sedentary lifestyle, unhealthy dietary habits, and stress contribute to the prevalence of digestive issues among the population. As a result, there is a strong need for effective remedies to address these concerns. The availability of a wide range of products in pharmacies has made it convenient for customers to access the remedies they need.

Underlying macroeconomic factors: The growing Digestive & Intestinal Remedies market in Bahrain can also be attributed to favorable macroeconomic factors. The country has witnessed steady economic growth, which has led to an increase in disposable income. As a result, customers are more willing to spend on healthcare products and are seeking out remedies to address their digestive health concerns. Additionally, the government's focus on promoting healthcare and wellness initiatives has also contributed to the growth of the market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Bahrain is experiencing significant growth due to customer preferences for natural and herbal remedies, the high prevalence of digestive disorders, and favorable macroeconomic factors. As customers become more health-conscious and seek preventive healthcare solutions, the demand for these remedies is expected to continue to rise in the coming years.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.